Diversify Wealth Management’s Castle Biosciences CSTL Stock Holding History

Diversify Wealth Management’s Portfolio CSTL Stock Details CSTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$389K	Buy	15,932 +172	+1%	+$3.83K	0.01%	959
2026 Q1	$382K	Buy	15,760 +4,172	+36%	+$137K	0.01%	887
2025 Q4	$459K	Sell	11,588 -159	-1%	-$5.13K	0.02%	455
2025 Q3	$305K	Sell	11,747 -575	-5%	-$11.7K	0.02%	452
2025 Q2	$238K	Sell	12,322 -780	-6%	-$14.4K	0.01%	491
2025 Q1	$260K	Buy	13,102 +717	+6%	+$17.8K	0.02%	453
2024 Q4	$375K	Sell	12,385 -1,013	-8%	-$30.9K	0.03%	400
2024 Q3	$428K	Sell	13,398 -1,358	-9%	-$34.6K	0.04%	341
2024 Q2	$322K	Buy	+14,756	New	+$329K	0.04%	346

Other funds holding CSTL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SPPAM

Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Diversify Wealth Management's CSTL Position: Q2 2026 in Review

Diversify Wealth Management increased its Castle Biosciences (CSTL) stake by 1.1% in Q2 2026, buying an estimated $3.83K and bringing the position to 15,932 shares worth $389K. The position accounts for 0.01% of the portfolio, ranked #959.

Diversify Wealth Management first reported a position in CSTL in Q2 2024 and has held it in 9 quarters since. The position peaked at $459K in Q4 2025. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

Diversify Wealth Management held 15,932 shares of Castle Biosciences worth $389K as of Q2 2026.
Diversify Wealth Management bought 172 Castle Biosciences shares in Q2 2026, an estimated $3.83K.
Castle Biosciences made up 0.01% of Diversify Wealth Management's portfolio in Q2 2026, its #959 holding.
Diversify Wealth Management first reported a position in Castle Biosciences in Q2 2024 and has held it in 9 quarters since.
Diversify Wealth Management's Castle Biosciences position peaked at $459K in Q4 2025.
177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Diversify Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.